Use of platelet-rich fibrin in aesthetics and facial rejuvenation: Integrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v10i9.17676

Keywords:

Platelet-rich fibrin; Facial rejuvenation; Tissue engineering; Cosmetic dentistry.

Abstract

Platelet-rich fibrin (PRF) is considered a filler biomaterial, currently used in both the medical and dental fields. This work aims to evaluate the use of PRF in aesthetic procedures and whether its use has rejuvenating action on the face. The study uses the terms "Platelet-rich fibrin", "Facial rejuvenation", "Tissue engineering" and "Cosmetic dentistry" to refine the search in the databases: PUBMED, MEDLINE and LILACS, between the beginning of the year 2016 to March of 2021. The criteria for inclusion of the articles were the use of the PRF in case studies and clinical trials in face rejuvenation. The exclusion criteria eliminated repeated studies that adopted a different design from the one mentioned above, or that addressed a therapy using the PRF that was not on the face. The search revealed experimental or observational studies considered eligible, which were included in the qualitative synthesis. The studies included showed that there is no standardization regarding the preparation of the PRF, with different application protocols for this biomaterial, and that although the authors were successful and observed improvement in relation to the appearance of the skin, there is a "high" or "undefined" risk bias favoring positive results. It was concluded that PRF is a safe material and has improved the appearance of the skin, requiring further studies to analyze its long-term effect.

References

Anitua, E. (1999). Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 14, 529-535.

Bielecki, T., & Dohan Ehrenfest, D. M. (2012). Platelet-rich plasma (PRP) and Platelet-Rich Fibrin (PRF): surgical adjuvants, preparations for in situ regenerative medicine and tools for tissue engineering. Curr Pharm Biotechnol. 13(7), 1121-1130.

Choukroun, J., Adda, F., Schoeffler, C. & Vervelle, A. (2001). Une opportunité en paro-implantologie: Le PRF. Implantodontie. 42, 55-62.

Choukroun, J. (2017). Platelet Rich Fibrin in regenerative dentistry: biological background and clinical indications. Wiley-Blackwell. 355-406.

Conselho Federal de Odontologia (2015). Resolução CFO Nº 158, de 8 de junho de 2015. Regulamenta o uso de Agregados Plaquetários Autólogos para fins não transfusionais no âmbito da Odontologia. Diário Oficial União.

Dohan Ehrenfest, D. M., Del Corso, M., Diss, A., Mouhyi, J. & Charrier, J. B. (2010). Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane. J Periodontol. 81(4), 546-55.

El Bagdadi, K., Kubesch, A., Yu, X., Al-Maawi, S., Orlowska, A., Dias, A. et al. (2017). Reduction of relative centrifugal forces increases growth factor release within solid platelet-rich-fibrin (PRF)-based matrices: a proof of concept of LSCC (low speed centrifugation concept). Eur J Trauma Emerg Surg.

Gentile, R. D. (2020). Easy Platelet-Rich Fibrin (Injectable/Topical) for Post-resurfacing and Microneedle Therapy. Facial Plast Surg Clin North Am. 28(1), 127-134.

Hassan, H., Quinlan, D. J. & Ghanem, A. (2020). Injectable platelet-rich fibrin for facial rejuvenation: A prospective, single-center study. J Cosmet Dermatol. 19(12), 3213-3221.

Hu, S., Bassiri-Tehrani, M. & Abraham, M. T. (2020). The Effect of Platelet-Rich Fibrin Matrix on Skin Rejuvenation: A Split-Face Comparison. Aesthet Surg J. 20, 244.

Karimi, K., & Rockwell, H. (2019). The Benefits of Platelet-Rich Fibrin. Facial Plast Surg Clin N Am. 27(1), 331-340.

Kubesch, A., Barbeck, M., Al-Maawi, S., Orlowska, A., Booms, P. F., Sader, R. A., Miron, R. J., Kirkpatrick, C. J., Choukroun, J. & Ghanaati, S. (2019). Um conceito de centrifugação de baixa velocidade leva ao acúmulo celular e vascularização de fibrina sólida rica em plaquetas: um estudo experimental in vivo. Platelets. 30(3), 329-340.

Liang, Z. J., Lu, X., Li, D. Q., Liang, Y. D., Zhu, D. D., Wu, F. X., Yi, X. L., He, N., Huang, Y. Q., Tang, C. & Li, H. M. (2018). Precise Intradermal Injection of Nanofat-Derived Stromal Cells Combined with Platelet-Rich Fibrin Improves the Efficacy of Facial Skin Rejuvenation. Cell Physiol Biochem. 47(1):316-329.

Lin, J. & Sclafani, A. P. (2018). Platelet-Rich Plasma for Skin Rejuvenation and Tissue Fill. Facial Plast Surg Clin North Am. 26(4), 439-446.

Marx, R. E., Carlson, E. R., Eichstaedt, R. M., Schimmele, S. R., Strauss, J. E. & Georgeff, K. R. (1998). Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 85, 638-646.

Mihaylova, Z., Mitev, V., Stanimirov, P., Isaeva, A., Gateva, N., Ishkitiev, N. et al. (2017). Use of platelet concentrates in oral and maxillofacial surgery: An overview. Acta Odontol Scand. 75, 1-1.

Nacopoulos, C. & Vesala, A. M. (2020). Lower facial regeneration with a combination of platelet-rich fibrin liquid matrices based on the low speed centrifugation concept-Cleopatra technique. J Cosmet Dermatol. 19(1), 185-189.

Nurden, A. T., Nurden, P., Sanchez, M., Andia, I. & Anitua, E. (2008). Plaquetas e cicatrização de feridas. Frente Biosci. 13, 3532-3548. 18508453.

Shahram Ghanaati, Patrick Booms, Anna Orlowska, Alica Kubesch, Jonas Lorenz, Jim Rutkowski, Constantin Landes, Robert Sader, CJ Kirkpatrick & Joseph Choukroun (2014). Advanced Platelet-Rich Fibrin: A New Concept for Cell-Based Tissue Engineering by Means of Inflammatory Cells. J Oral Implantol. 40(6), 679–689.

Simonpieri. A., Del Corso, M., Vervelle, A., Jimbo, R., Inchingolo, F. & Sammartino, G. et al. (2012). Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: bone graft, implant and reconstructive surgery. Curr Pharm Biotechnol. 13(7), 1231-1256.

Souza, M. T., Silva, M. D., & Carvalho, R. (2010). Revisão integrativa: o que é e como fazer. Rev Einstein, 8(1), 102-6.

Storrer, C. L. M., Andrade, C. F., Chaves, L. H. K., Wambier, L. M., De-Geus, J. L. & Zielak J. C. (2019). Injeção de agregados plaquetários no rejuvenescimento facial: uma revisão sistemática. Rev. Bras. Cir. Plást. 34(2), 274-282.

Wang, X., Zhang, Y., Choukroun, J., Ghanaati, S. & Miron, R. J. (2017). Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets. 29, 1–8.

Wei, H., Gu, S. X., Liang, Y. D., Liang, Z. J., Chen, H., Zhu, M. G., Xu, F. T., He, N., Wei, X. J. & Li, H. M. (2017). Nanofat-derived stem cells with platelet-rich fibrin improve facial contour remodeling and skin rejuvenation after autologous structural fat transplantation. Oncotarget. 8(40), 68542-68556.

Whitmann, D. H., Berry, R. L. & Green, D. M. (1997). Platelet gel: an alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 55, 1294-1299.

Downloads

Published

24/07/2021

How to Cite

FALCÃO, L. R. M. .; ROCHA, S. M. W. .; MOTA, K. R. .; MALTA, T. A. J. .; RIOS, R. A. A. .; FERNANDES, K. J. de M. .; TENÓRIO NETO, J. F.; NASCIMENTO, R. S. V. do . Use of platelet-rich fibrin in aesthetics and facial rejuvenation: Integrative review. Research, Society and Development, [S. l.], v. 10, n. 9, p. e19610917676, 2021. DOI: 10.33448/rsd-v10i9.17676. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/17676. Acesso em: 22 nov. 2024.

Issue

Vol. 10 No. 9

Section

Health Sciences

License

Copyright (c) 2021 Lyles Regina Machado Falcão; Stella Maris Wanderley Rocha; Kelly Rodrigues Mota; Taianne Aída Joia Malta; Roberta Albuquerque Acioli Rios; Katharina Jucá de Moraes Fernandes; João Francisco Tenório Neto; Rômulo Savage Vanderlan do Nascimento

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.